In men who are overweight or obese, adding testosterone therapy reduced glucose intolerance/T2DM

Wittert G, Bracken K, Robledo KP, et al. Lancet Diabetes Endocrinol. 2021;9:32-45. 33338415.

Saved in:
Bibliographic Details
Published inAnnals of internal medicine Vol. 174; no. 5; p. JC54
Main Authors Griffin, Tomás P, Dinneen, Sean F
Format Journal Article
LanguageEnglish
Published United States 01.05.2021
Online AccessGet more information

Cover

Abstract Wittert G, Bracken K, Robledo KP, et al. Lancet Diabetes Endocrinol. 2021;9:32-45. 33338415.
AbstractList Wittert G, Bracken K, Robledo KP, et al. Lancet Diabetes Endocrinol. 2021;9:32-45. 33338415.
Author Dinneen, Sean F
Griffin, Tomás P
Author_xml – sequence: 1
  givenname: Tomás P
  surname: Griffin
  fullname: Griffin, Tomás P
  organization: Galway University Hospitals, Galway, Ireland (T.P.G., S.F.D.)
– sequence: 2
  givenname: Sean F
  surname: Dinneen
  fullname: Dinneen, Sean F
  organization: Galway University Hospitals, Galway, Ireland (T.P.G., S.F.D.)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33939479$$D View this record in MEDLINE/PubMed
BookMark eNo1j81OAjEURhujkR99ADemD-BIe9tpO0uCqBiMLnCNnfYOjIGWtIOEt5dEXX2Lk5yTb0DOQwxIyA1n91qAGo0n7y_AgLOSG1awUp6RPi9FVQjNZI8Mcv5ijAkD5pL0hKhEJXXVJ5-zQLcY6GEdqU1I4zemA7ardUdjorHGjHfUet-GFe0wdzF3mE5l2q0x2d2RJvR7h56uNnsXM9I2dHFzQsHhaAEPr1fkorGbjNd_OyQfj9PF5LmYvz3NJuN54cDwrnCmrlyFyluQNWBpoWmUKqVGKyUIhRU02BhWC6Z8bdE4q0Br7hk3FrSDIbn99e729Rb9cpfarU3H5f9V-AFmbFeM
ContentType Journal Article
DBID NPM
DOI 10.7326/ACPJ202105180-054
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1539-3704
ExternalDocumentID 33939479
Genre Journal Article
GroupedDBID ---
..I
.55
.GJ
.XZ
08G
1CY
23M
2WC
354
36B
39C
3O-
3V.
4.4
53G
5GY
5RE
5RS
6J9
7RV
7X7
88E
8C1
8F7
8FI
8FJ
8G5
8R4
8R5
AAKAS
AAQOH
AAQQT
AARDX
AAWTL
AAYOK
ABBLC
ABCQX
ABJNI
ABOCM
ABPMR
ABUWG
ACBNA
ACGFO
ACGFS
ADBBV
ADZCM
AEGXH
AENEX
AERZD
AETEA
AFCHL
AFFNX
AFKRA
AHJKT
AHMBA
AI.
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AQUVI
ASPBG
AVWKF
AZFZN
AZQEC
BCR
BCU
BEC
BENPR
BKEYQ
BKNYI
BLC
BPHCQ
BTJBQ
BVXVI
BZLQD
C1A
C45
CCPQU
DWQXO
E3Z
EBS
EJD
EMB
EMOBN
EX3
F5P
FEDTE
FYUFA
G8K
GNUQQ
GUQSH
HMCUK
HVGLF
H~9
IH2
J5H
K-O
K9-
L7B
LPU
M0R
M0T
M1P
M2O
M5~
MV1
MVM
N4W
NAPCQ
NPM
OBH
OCB
OFXIZ
OGEVE
OHH
OHT
OVD
OVIDX
P2P
PCD
PQQKQ
PROAC
PSQYO
Q2X
RWL
RXW
S0X
SJFOW
SJN
SV3
TAE
TEORI
TPH
TR2
TWZ
UKHRP
UKR
VH1
VVN
WH7
WOQ
WOW
X6Y
X7M
XOL
YFH
YOC
YQJ
YYP
ZA5
ZGI
ZXP
ZY1
~H1
ID FETCH-LOGICAL-c281t-c8b9c9e6da24b2e5a2ff66547ea44236e92fef80b306dbae8ca62771d018a27c2
IngestDate Thu May 23 23:39:48 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c281t-c8b9c9e6da24b2e5a2ff66547ea44236e92fef80b306dbae8ca62771d018a27c2
PMID 33939479
ParticipantIDs pubmed_primary_33939479
PublicationCentury 2000
PublicationDate 2021-May
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-May
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Annals of internal medicine
PublicationTitleAlternate Ann Intern Med
PublicationYear 2021
SSID ssj0003828
Score 2.405248
Snippet Wittert G, Bracken K, Robledo KP, et al. Lancet Diabetes Endocrinol. 2021;9:32-45. 33338415.
SourceID pubmed
SourceType Index Database
StartPage JC54
Title In men who are overweight or obese, adding testosterone therapy reduced glucose intolerance/T2DM
URI https://www.ncbi.nlm.nih.gov/pubmed/33939479
Volume 174
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFLcGkxCXiY3Bxsfkw25dgDhOYh-rFgaViiYNJG4sdp4FEk0Q62X763nPTpqsjGnbJYriprX8fnp93z_GPpZgcqlBROAEOiiZlpGWMo1coqywxlrp28em59nppZxcpVddKNt3l8zNgf35276S_5EqPkO5UpfsP0h28aX4AO9RvnhFCeP1r2R8Vg1m1Id9Uw-ogKv2Rc7kbVOVeW0gkCZSyRD1RBGHDI1FqNGuDG1XPwYPNLkVbc62cv22mtd3QGQbQGNFxHjat167acu3IZB49yQ3_9kHgQLlcT3zafj4e9dENiaqr6DpvlIO4KQfdUAxLmr8DqDVlBq1U-AOXqjSwLjTYCbtKcbJKMyKXtbYeeI5JoejLxP6GVQRipLzv3wWD_1-5kWYJDrRMrDP_Hl1aYh2u7TCVnJFivCcgjrNH3aCXmdIeNNuDp_sZZ2tte8vOR_eCLnYYK8a74EPAxResxdQvWFr00YGm-zbWcURERwRwRERvEMErx-4R8QnHvDA-3jgDR54gwfe4IH38HBIaHjLLk-OL0anUcOhEVmh4nlkldFWQ1YWQhoBaSGc84TTUEi0pDPQwoFTRwZdx9IUoGyRiTyPy6NYFSK3YoutVriPd4xrGg8XpybJ01I6k2iVOZsBpDRwCO3g92w7nM31fRiUct2e2s6zK7tsvUPXHnvpEMWwj2be3HzwQnoEYDRQzw
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+men+who+are+overweight+or+obese%2C+adding+testosterone+therapy+reduced+glucose+intolerance%2FT2DM&rft.jtitle=Annals+of+internal+medicine&rft.au=Griffin%2C+Tom%C3%A1s+P&rft.au=Dinneen%2C+Sean+F&rft.date=2021-05-01&rft.eissn=1539-3704&rft.volume=174&rft.issue=5&rft.spage=JC54&rft_id=info:doi/10.7326%2FACPJ202105180-054&rft_id=info%3Apmid%2F33939479&rft_id=info%3Apmid%2F33939479&rft.externalDocID=33939479